BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
See today's BioWorld MedTech
Home
» Court Report: Medtronic to pay $268M to settle Sprint Fidelis suits
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Court Report: Medtronic to pay $268M to settle Sprint Fidelis suits
Oct. 15, 2010
By
Amanda Pedersen
No Comments
Medtronic (Minneapolis) said Thursday it will pay $268 million to settle U.S. lawsuits related to its Sprint Fidelis family of defibrillation leads which the company recalled three years ago. (Medical Device Daily)
BioWorld MedTech